N/A N=204 AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID
Surgical Wound
Primary: Time to Ambulation (TTA) — 2.8; 6.1 hours
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=109 Comparison of Percutaneous Closure to Manual Compression for Hemostasis
Atrial Fibrillation
Primary: Time to Hemostasis — 4.5; 10.7 seconds
N/A N=50 Comparing Perclose to Statseal With Perclose in Transcatheter Aortic Valve Replacement Arteriotomy Closure
Arterial Occlusion · Cardiovascular Diseases · Hematoma
Primary: Time to Hemostasis — 5.11; 4.3 minutes
N/A N=70 Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture
Atrial Fibrillation
Primary: Time Required to Achieve Hemostasis — 0; 15 minutes
N/A N=75 Caring for the Radial Artery Post-angiogram
Transradial Angiogram
Primary: Bleeding Requiring Intervention After Initial Hemostasis Achieved — 2; 6; 3 participants — p=0.25
N/A N=106 Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial
Atrial Fibrillation · Atrial Flutter · Heart Block
Primary: Time to Achieve Hemostasis — 7; 11 Minutes
N/A N=92 This Study Will Evaluate the Safety and Potential Complications of Dual ProGlide vs Single ProGlide and Angioseal for Common Femoral Arteriotomy Closure Following Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement · Closure Technique
Primary: Number of Participants With Main Access-related Bleeding and Vascular Complications — 47; 42 Participants
N/A N=75 Safety and Performance Study of Large Hole Vascular Closure Device FIV
Percutaneous CFA Arteriotomy Closure
Primary: Major Vascular Complications [Safety] — 0 Participants — p=<.0001
Phase 4 N=240 AngioSeal Versus Radial Approach in Acute Coronary Syndrome
Acute Coronary Syndrome
Primary: First Occurrence of Access Site Related Ischemic or Bleeding Complication — 16; 15 Participants
N/A N=147 Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
Vascular Closure
Primary: Freedom From Major Complications — 83 Participants
N/A N=12 Safety and Performance Study of Large Hole Vascular Closure Device
Percutaneous Closure of Arteriotomy in Common Femoral Artery
Primary: Major Vascular Complications Directly Related to Device — 0 percentage of participants
N/A N=168 AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)
Surgical Wound
Primary: Number of Participants With Overall Procedure Success - Effectiveness — 168 Participants
N/A N=220 The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System
Surgical Wound
Primary: Time to Hemostasis — 1.78 minutes
Phase 3 N=488 Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device
Angioplasty, Transluminal, Percutaneous Coronary · Coronary Arteriosclerosis · Peripheral Arteriosclerosis
Primary: Time to Hemostasis (TTH) — 4.68; 4.38; 20.05 Minutes — p=<0.0001
N/A N=434 VAscular Closure for Cardiac Ablation Registry (VACCAR)
Atrial Fibrillation
Primary: Hemostasis — 9; 20; 7 minutes
Phase 4 N=208 The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure
Cardiac Diagnostic Procedure · Cardiac Interventional Procedure · Femoral Access Site Closure
Primary: Assessment of Venous Thrombosis — 0; 0 Participants
N/A N=263 MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study
Femoral Arteriotomy Closure
Primary: Time to Hemostasis — 65.4 seconds
N/A N=1,004 Femoral Arterial Access With Ultrasound Trial
Vascular Access Complications · Cardiac Catheterization · Peripheral Vascular Disease
Primary: Participants With Successful Common Femoral Artery Cannulation, as Determined by Femoral Angiography — 408; 431 participants
N/A N=36 Perclose Multi-Access Duplex Ultrasound (DUS) Study
Arrhythmia
Primary: Number of Subjects With Major Vascular Complications by DUS Detection at Discharge — 0; 0; 0; 0 Participants
N/A N=207 Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)
Cardiac Disease · Coronary Artery Disease
Primary: The Primary Safety Endpoint Will be the Combined Rate of Major Complications With in 30 +/- 7 Days Following the Percutaneous Coronary Intervention (PCI) Procedure. — 1…
N/A N=38 A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
Peripheral Vascular Disease
Primary: Device-Related Adverse Events — 0 Proportion of Participants that Experien
N/A N=47 X-Seal EU Post-Market Clinical Follow-Up Protocol
Femoral Arteriotomy Closure
Primary: Major Complications — 0; 0 Participants
N/A N=351 A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Diagnostic Catheterization Access Through a 5F or 6F Femoral Artery Introducer
Primary: Observation of Any Site Related Complications Recorded as Either Major or Minor Adverse Events.
N/A N=326 ClosureFAST - Radiofrequency Great Saphenous Vein Treatment
Venous Reflux
Primary: Percentage of Limbs Without Vein Occlusion — 97.6 percentage of limbs
N/A N=420 RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)
Surgical Wound
Primary: Time to Hemostasis (TTH) — 21.4; 4.8 minutes
N/A N=64 Patient Comfort With Vascular Closure
Vascular Closure
Primary: Mean Score on the Visual Analogue Scale — 0.63; 0.59; 2.94; 5.03 Scores on a Scale
N/A N=160 Novel Angioplasty Using Coronary Accessor
Patency of the Radial Artery
Primary: Number of Patients With Radial Artery Occlusion — 3; 0 Participants
N/A N=56 Orthopaedic Surgical Wound Closure Comparison Study
Incision, Surgical
Primary: Stony Brook Scar Evaluation Scale — 2.8; 4.09; 3.45 score on a scale
N/A N=235 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device
Vascular Closure
Primary: The Percentage of Subjects Experiencing a Device or Procedure Related Major Vascular Complication — 2.8 % of subjects with MVCs — p=0.0029
N/A N=19 34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms
Abdominal Aortic Aneurysm
Primary: Number of Participants With Proximal Type I Endoleak at Each Timepoint — 1; 0; 0; 0 Participants